A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

'Dry Liposome Adjuvant-Containing Vaccines And Related Methods Thereof' in Patent Application Approval Process (USPTO 20230060631)
Published: March 22, 2023 by NewsRx Pharma Business Daily
Reuters reports GSK, Moderna, CSL Seqirus all working on bird flu vaccinations for humans focused on currently circulating bird flu subtype; in US, bird flu has killed about 58 million birds, although human cases worldwide have remained very rare
Published: March 21, 2023 by Medical Daily
Patent Application Titled 'Immunogenic Composition' Published Online (USPTO 20230060184)
Published: March 17, 2023 by NewsRx Pharma Business Daily
GSK announces positive results from phase III trial of 5-in-1 meningococcal ABCWY vaccine candidate
Published: March 15, 2023 by PharmaBiz (India)
GSK releases 2022 ESG Performance Report; highlights include 100% of GSK sites meet Alliance for Water Stewardship’s good water steward requirements, GSK reduced scope 1 and 2 operational emissions by 6% from 2021
Published: March 10, 2023 by U.S. Regulated Equity Markets (Alternative Disclosure) via PUBT

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count